Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. James “Jim” R. Poliquin, RPVI, FACS, FSVM, is a vascular and endovascular surgeon in the Department of Vascular Surgery in the Sydell and Arnold Miller Family Heart & Vascular Institute. He is board certified in surgery and endovascular medicine. His specialty interests include minimally invasive endovascular procedures to open diseased blood vessels with balloon angioplasty and stenting, abdominal aortic aneurysm repair (both open and endograft), aorto- femoral bypass, femoral popliteal/tibial/distal bypass, carotid endarterectomy, arterio-venous surgery, venous access catheters and venous disease treatment.
A graduate of the Medical College of Virginia, Richmond, Va., Dr. Poliquin served a surgical internship at Tripler Army Medical Center, Honolulu, Hawaii, followed by three years as a flight surgeon and general medical officer with the U.S. Army.
After his military service, Dr. Poliquin completed a general surgery residency at Eastern Virginia Medical School, Norfolk, Va., and a vascular surgery fellowship at St. Vincent Medical Center, Medical College of Ohio, Toledo, Ohio. Dr. Poliquin completed his endovascular fellowship at the Cleveland Clinic and joined the Cleveland Clinic medical staff in 2009. He left in 2011, only to miss the camaraderie and excellence, and rejoined the Cleveland Clinic in 2013.
He is a fellow of the American College of Surgeons and the Society for Vascular Medicine and is a member of numerous professional organizations, including the Peripheral Vascular Surgical Society and the Society of American Gastrointestinal Endoscopic Surgeons.
In his leisure time Dr. Poliquin enjoys tennis, swimming and spending time with his family.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 3/7/2014 the review process regarding Dr. Poliquin's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.